Related Experiment Video
Updated: Mar 23, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment
Kentaro Inamura1, Yuichi Ishikawa2
1Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan. kentaro.inamura@jfcr.or.jp.
Abstract:
Lung cancer is the leading cause of cancer death in men and women worldwide. The lack of specific and sensitive tools for early diagnosis as well as still-inadequate targeted therapies contribute to poor outcomes. MicroRNAs are small non-coding RNAs, which regulate gene expression post-transcriptionally by translational repression or degradation of target mRNAs. A growing body of evidence suggests various roles of microRNAs including development and progression of lung cancer. In lung cancer, several studies have showed that certain microRNA profiles classified lung cancer subtypes, and that specific microRNA expression signatures distinguished between better-prognosis and worse-prognosis lung cancers. Furthermore, microRNAs circulate in body fluids, and therefore may serve as promising biomarkers for early diagnosis of lung cancer as well as for predicting prognosis of patients. In the present review, we briefly summarize microRNAs in the development and progression of lung cancer, focusing on possible applications of microRNAs as novel biomarkers and tools for treatment.
Insights
MicroRNAs play a key role in lung cancer development and progression. These small molecules show promise as biomarkers for early diagnosis and as novel therapeutic targets for lung cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Lung cancer remains a leading cause of cancer mortality globally.
- Current diagnostic tools and therapies for lung cancer have limitations, contributing to poor patient outcomes.
- MicroRNAs (miRNAs), small non-coding RNAs, regulate gene expression and are implicated in various biological processes, including cancer.
Purpose of the Study:
- To review the role of microRNAs in lung cancer development and progression.
- To explore the potential of microRNAs as biomarkers for early lung cancer diagnosis.
- To discuss microRNAs as potential therapeutic targets for lung cancer treatment.
Main Methods:
- Literature review of studies on microRNAs in lung cancer.
- Analysis of research on microRNA expression profiles and their correlation with lung cancer subtypes and prognosis.
- Investigation of microRNAs' presence in body fluids for biomarker potential.
Main Results:
- MicroRNA profiles can classify lung cancer subtypes.
- Specific microRNA expression signatures differentiate between favorable and unfavorable prognoses.
- Circulating microRNAs in body fluids suggest potential as diagnostic and prognostic biomarkers.
Conclusions:
- MicroRNAs are significantly involved in the development and progression of lung cancer.
- MicroRNAs hold promise as novel biomarkers for early detection and prognosis prediction in lung cancer.
- MicroRNAs represent potential novel tools for targeted lung cancer therapies.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs

